Assessing the incidence of gestational diabetes and neonatal outcomes using the IADPSG guidelines in comparison with the Carpenter and Coustan criteria in a Belgian general hospital

We have conducted a systematic universal screening for gestational diabetes mellitus (GDM) since 2008, following the criteria outlined by the International Association of Diabetes and Pregnancy Study Group (IADPSG) since 2011. However, we recently replaced the IADPSG standards with those established...

Full description

Saved in:
Bibliographic Details
Published in:Acta clinica belgica (English ed. Online) 2014, Vol.69 (1), p.8-11
Main Authors: Oriot, P., Selvais, P., Radikov, J., Jacobs, J. L., Gilleman, U., Loumaye, R., Fernandez, C.
Format: Article
Language:English
Subjects:
Adult
Age
Belgium - epidemiology
Blood Glucose - analysis
Body mass index
Carpenter and Coustan criteria
Cesarean Section - statistics & numerical data
Diabetes
Diabetes, Gestational - diagnosis
Diabetes, Gestational - epidemiology
Diabetes, Gestational - prevention & control
Early Diagnosis
Female
Gestational Age
Glucose
Guideline Adherence
Hospitals, General
Humans
IADPSG criteria
Incidence
Insulin
Insulin therapy
Neonatal outcomes
Nurses
Obstetrics
Patients
Plasma
Pregnancy
Pregnancy Outcome
Retrospective Studies
Risk factors
Studies
Universal screening of gestational diabetes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We have conducted a systematic universal screening for gestational diabetes mellitus (GDM) since 2008, following the criteria outlined by the International Association of Diabetes and Pregnancy Study Group (IADPSG) since 2011. However, we recently replaced the IADPSG standards with those established by the Belgian French Language Gynecologists and Obstetricians Group (GGOLFB). These new criteria indicate GDM when fasting plasma glucose (FPG) is ⩾0·92 g/l at the beginning of pregnancy or when an orally provoked hyperglycaemia test (75 g of glucose) between the twenty-fourth and twenty-eighth week results in an FPG of ⩾0·92 g/l and/or ⩾1·80 g/l after 1 hour and/or ⩾1·53 g/l after 2 hours. The goal of this retrospective study was to evaluate the incidence of GDM, neonatal outcomes, and the use of insulin therapy 21 months post-implementation of the IADPSG criteria within our centre. A total of 393 patients were diagnosed with GDM from January 2009 to December 2012. After applying the new criteria, the incidence of GDM rose significantly from 8 to 23% (P
ISSN:1784-3286
2295-3337
DOI:10.1179/0001551213Z.0000000004